An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL

Leukemia, Published online: 30 August 2019; doi:10.1038/s41375-019-0569-7An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
Source: Leukemia - Category: Hematology Authors: Source Type: research
More News: Hematology | Leukemia